Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts

Cancer Chemotherapy and Pharmacology

Volumn 48, Issue 4, 2001, Pages 283-288

  Jang, Yuh ^a   Wang, Yen Ho ^a   Wang, Jung Der ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Docetaxel; Fluoropyrimidines; IL 6; Phosphorylase; Thymidine

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DOXIFLURIDINE; ENZYME; FLUOROPYRIMIDINE; INTERLEUKIN 6; TEGAFUR; THYMIDINE PHOSPHORYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESEARCH; ENZYME ACTIVITY; FEMALE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CACHEXIA; DRUG INTERACTIONS; FEMALE; FLOXURIDINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; PACLITAXEL; TAXOIDS; TEGAFUR; THYMIDINE PHOSPHORYLASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0034852604     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100325     Document Type: Article

References (29)

1. Preclinical pharmacology of docetaxel
2. Taxanes in combination with doxorubicin in the treatment of metastatic breast cancer
3. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors
4. Docetaxel in combination chemotherapy for metastatic breast cancer
5. Docetaxel in combination with fluorouracil for advanced solid tumors
6. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts
7. Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer
8. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil
9. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
10. Isolation and characterisation of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
11. Medroxyprogesterone acetate inhibits interleukin-6 secretion from KPL-4 human breast cancer cell line both in vitro and in vivo: A possible mechanism of the anti-cachectic effect
12. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues
13. Evaluation of interleukin-6 (IL-6) measurement by highly sensitive chemiluminescent enzyme immunoassay
14. Phase I and pharmacokinetic study of Xeloda (capecitabine) in combination with docetaxel
15. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
16. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil
17. Cachectin and tumor necrosis factor as two sides of the same biological coin
18. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice
19. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
20. Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by interleukin-11/adipogenesis inhibitory factor
21. Severe cachexia in mice inoculated with interferon-γ-producing tumor cells
22. Effects of leukemia inhibitory factor on hematopoietic and other tissues in mice
23. Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma
24. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft
25. Murine interleukin-12 prevents the development of cancer cachexia in a murine model
26. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor
27. The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer
28. Expression of the angiogenic factors vascular endothelial growth factor, acidic and basic fibroblast growth factor, tumor growth factor-beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
29. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis